Publication | Closed Access

Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function

Ribavirin-free TherapyHepatologyViral HepatitisImmunologyAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapyAntiviral ResponseVascular BiologyAntiviral DrugMedicineVascular Endothelial FunctionChronic Hepatitis C